Travere Therapeutics, Inc. revenue breakdown overview

Travere Therapeutics, Inc. revenue for the last year amounted to 226.71 M USD, the most of which — 132.22 M USD — came from its highest performing source at the moment, FILSPARI, the year earlier bringing 29.21 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Travere Therapeutics, Inc. 226.71 M USD, and the year before that — 127.54 M USD.